Study identification

PURI

https://redirect.ema.europa.eu/resource/39922

EU PAS number

EUPAS37225

Study ID

39922

Official title and acronym

Project Sc(y)lla: SARS-Cov-2 Large-scale Longitudinal Analyses on the comparative safety and effectiveness of treatments under evaluation for COVID-19 across an international observational data network

DARWIN EU® study

No

Study countries

France
Germany
Korea, Republic of
Netherlands
United Kingdom
United States

Study status

Planned
Research institution and networks

Institutions

SIDIAP Spain, IPCI Netherlands

Networks

Contact details

Daniel Prieto-Alhambra

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

Bill and Melinda Gates Foundation, IMI EHDEN, Others
Study protocol
Initial protocol
English (1.03 MB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable